Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.78B |
| 2 |
Microsoft
MSFT
|
+$2.22B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.67B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.65B |
| 5 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.19B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.45B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$533M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$410M |
| 4 |
Stellantis
STLA
|
+$312M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.28% |
| 2 | Healthcare | 11.27% |
| 3 | Financials | 10.52% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
FormFactor
FORM
$9B
| $2.05M | ﹤0.01% |
59,879
+12,900
| +27% | +$385K |
|
1827
Mueller Water Products
MWA
$4.24B
| $2.05M | ﹤0.01% |
126,006
+33,808
| +37% | +$481K |
|
1828
Caleres
CAL
$486M
| $2.04M | ﹤0.01% |
85,413
+53,404
| +167% | +$1.2M |
|
|
MBSC
1829
DELISTED
M3-Brigade Acquisition III Corp.
MBSC
| $2.04M | ﹤0.01% |
195,218
| – | – |
|
1830
Gibraltar Industries
ROCK
$1.51B
| $2.04M | ﹤0.01% |
32,350
+4,720
| +17% | +$255K |
|
1831
Canadian Natural Resources
CNQ
$94.8B
| $2.03M | ﹤0.01% |
72,196
-350,912
| -83% | -$10M |
|
1832
Schrodinger
SDGR
$1.33B
| $2.03M | ﹤0.01% |
40,680
+932
| +2% | +$31.5K |
|
1833
Magna International
MGA
$18.1B
| $2.02M | ﹤0.01% |
35,858
-39,744
| -53% | -$2.11M |
|
|
SPR
1834
DELISTED
Spirit AeroSystems
SPR
| $2.02M | ﹤0.01% |
69,286
-85,749
| -55% | -$2.47M |
|
|
FINV
1835
FinVolution Group
FINV
$1.14B
| $2.01M | ﹤0.01% |
435,986
| – | – |
|
1836
PagerDuty
PD
$856M
| $2M | ﹤0.01% |
89,079
-48,685
| -35% | -$1.35M |
|
|
VBTX
1837
DELISTED
Veritex Holdings
VBTX
| $2M | ﹤0.01% |
111,671
+53,688
| +93% | +$956K |
|
1838
Werner Enterprises
WERN
$2.21B
| $2M | ﹤0.01% |
45,290
+6,555
| +17% | +$295K |
|
1839
Middlesex Water
MSEX
$1.08B
| $2M | ﹤0.01% |
24,776
+15,844
| +177% | +$1.24M |
|
1840
Buckle
BKE
$2.36B
| $1.99M | ﹤0.01% |
57,653
+41,204
| +250% | +$1.38M |
|
|
DCPH
1841
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $1.99M | ﹤0.01% |
141,595
+16,026
| +13% | +$229K |
|
1842
iPath Select MLP ETN
ATMP
$631M
| $1.99M | ﹤0.01% |
+100,000
| New | +$1.91M |
|
1843
APi Group
APG
$17.8B
| $1.99M | ﹤0.01% |
109,455
-48,272
| -31% | -$747K |
|
1844
Arcosa
ACA
$7.12B
| $1.99M | ﹤0.01% |
26,241
+616
| +2% | +$41.4K |
|
1845
Liberty Global Class A
LBTYA
$3.68B
| $1.99M | ﹤0.01% |
117,754
-4,702
| -4% | -$83.5K |
|
1846
Karyopharm Therapeutics
KPTI
$44.2M
| $1.98M | ﹤0.01% |
73,757
-116,069
| -61% | -$5M |
|
1847
CALL
American Tower
AMT
$79.8B
| $1.98M | ﹤0.01% |
+10,200
| New | +$1.99M |
|
1848
Invesco Mortgage Capital
IVR
$758M
| $1.97M | ﹤0.01% |
172,004
+153,564
| +833% | +$1.64M |
|
|
PLGO
1849
Pelagos Insurance Capital
PLGO
$2.18B
| $1.97M | ﹤0.01% |
+144,000
| New | +$1.91M |
|
1850
Chegg
CHGG
$98.4M
| $1.96M | ﹤0.01% |
221,259
+24,241
| +12% | +$294K |
|
Similar funds
Barclays's Q2 2023 Portfolio in Review
As of Q2 2023, Barclays held 5,371 positions worth $158B, down 28% from $218B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays withdrew a net $70.1B in Q2 2023, closing 872 positions and reducing 1,669 holdings. Its most notable exit was DCP Midstream, LP, an estimated $47.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR Nuveen ICE Municipal Bond ETF worth $36.9M.
- Barclays's largest Q2 2023 buy was State Street SPDR Nuveen ICE Municipal Bond ETF: 799,988 shares worth $36.9M.
- Barclays added most to Apple in Q2 2023, an estimated $2.78B increase.
- Barclays's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.45B.
- Barclays fully exited DCP Midstream, LP in Q2 2023, selling an estimated $47.3M.
- Barclays's ten largest holdings make up 24% of its $158B portfolio in Q2 2023.
- Barclays opened 314 new positions and closed 872 in Q2 2023.
- Barclays's portfolio value fell 28% quarter-over-quarter to $158B.
Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.